The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Mesenchymal stem cells suppress B-cell terminal differentiation
Open accessAbstract
Objective Mesenchymal stem cells (MSCs) have been shown to possess immunomodulatory properties on a diverse array of immune cell lineages. However, their effect on B-lymphocytes has remained unclear. We investigated the effect of MSCs on B cell modulation with a special emphasis on gene regulation mediated by MSC humoral factors. Methods MSCs were isolated from C57BL/6 bone marrow and expanded in culture. Splenic B cells were purified using anti-CD43 antibody and immunomagnetic beads. B cells and MSCs were co-cultured in separate compartments in a transwell system. For B cell stimulation, lipopolysaccharide (LPS) was used in vitro and T-dependent and T-independent antigens were used in vivo. Results In MSC co-cultures, LPS-stimulated B cell proliferation was suppressed, CD138+ cell percentage decreased, and the number of apoptotic CD138+ cells decreased. In the B/MSC co-culture, the IgM+ cell percentage was higher and the IgM amount released in the medium was lower than in the control. The Blimp-1 mRNA expression in the co-culture was suppressed throughout the 3 day culture period. Conditioned media derived from MSC cultures prevented the terminal differentiation of B cells in vitro and significantly suppressed the antigen specific IgM and IgG1 secretion in mice immunized with T cell-independent as well as T cell-dependent antigens in vivo. Conclusion Results indicate that humoral factor(s) released by MSCs exert a suppressive effect on the B cell terminal differentiation. The suppression may be mediated through inhibition of Blimp-1 expression, but the nature of the factor(s) is yet to be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrow
Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., et al. (2002) · Nature · doi:10.1038/nature00870 · Cited by 5,518
RetractedMultilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Horwitz, E. M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Deans, R. J., Krause, D. S., & Keating, A. (2005) · Cytotherapy · doi:10.1080/14653240500319234 · Cited by 2,073
Immunomodulatory properties of mesenchymal stromal cells
Nauta, A. J., & Fibbe, W. E. (2007) · Blood · doi:10.1182/blood-2007-02-069716 · Cited by 1,788
Human mesenchymal stem cells modulate B-cell functions
Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Gualandi, F., Mancardi, G. L., Pistoia, V., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2657 · Cited by 1,767
Meisel, R., Zibert, A., Laryea, M., Göbel, U., Däubener, W., & Dilloo, D. (2004) · Blood · doi:10.1182/blood-2003-11-3909 · Cited by 1,646
Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E., & Dazzi, F. (2003) · Blood · doi:10.1182/blood-2002-07-2104 · Cited by 1,598
Jiang, X.-X., Zhang, Y., Liu, B., Zhang, S.-X., Wu, Y., Yu, X.-D., & Mao, N. (2005) · Blood · doi:10.1182/blood-2004-02-0586 · Cited by 1,346
Role for Interferon-γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells
Krampera, M., Cosmi, L., Angeli, R., Pasini, A., Liotta, F., Andreini, A., Santarlasci, V., Mazzinghi, B., Pizzolo, G., Vinante, F., et al. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0008 · Cited by 1,311
Plasma cell differentiation requires the transcription factor XBP-1
Reimold, A. M., Iwakoshi, N. N., Manis, J., Vallabhajosyula, P., Szomolanyi-Tsuda, E., Gravallese, E. M., Friend, D., Grusby, M. J., Alt, F., & Glimcher, L. H. (2001) · Nature · doi:10.1038/35085509 · Cited by 1,305
Kinnaird, T., Stabile, E., Burnett, M. S., Shou, M., Lee, C. W., Barr, S., Fuchs, S., & Epstein, S. E. (2004) · Circulation · doi:10.1161/01.cir.0000124062.31102.57 · Cited by 1,305
Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells
Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W.-F., & Dazzi, F. (2005) · Blood · doi:10.1182/blood-2004-09-3696 · Cited by 1,150
Spaggiari, G. M., Capobianco, A., Becchetti, S., Mingari, M. C., & Moretta, L. (2006) · Blood · doi:10.1182/blood-2005-07-2775 · Cited by 1,067
Peister, A., Mellad, J. A., Larson, B. L., Hall, B. M., Gibson, L. F., & Prockop, D. J. (2004) · Blood · doi:10.1182/blood-2003-09-3070 · Cited by 994
Stem cells in tissue engineering
Bianco, P., & Robey, P. G. (2001) · Nature · doi:10.1038/35102181 · Cited by 965
Control of Inflammation, Cytokine Expression, and Germinal Center Formation by BCL-6
Dent, A. L., Shaffer, A. L., Yu, X., Allman, D., & Staudt, L. M. (1997) · Science · doi:10.1126/science.276.5312.589 · Cited by 945
Regulation of plasma-cell development
Shapiro-Shelef, M., & Calame, K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1572 · Cited by 881
Shapiro-Shelef, M., Lin, K.-I., McHeyzer-Williams, L. J., Liao, J., McHeyzer-Williams, M. G., & Calame, K. (2003) · Immunity · doi:10.1016/s1074-7613(03)00267-x · Cited by 839
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation
Ye, B. H., Cattoretti, G., Shen, Q., Zhang, J., Hawe, N., Waard, R. D., Leung, C., Nouri-Shirazi, M., Orazi, A., Chaganti, R. S. K., et al. (1997) · Nature Genetics · doi:10.1038/ng0697-161 · Cited by 820
Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination
Klein, U., Casola, S., Cattoretti, G., Shen, Q., Lia, M., Mo, T., Ludwig, T., Rajewsky, K., & Dalla-Favera, R. (2006) · Nature Immunology · doi:10.1038/ni1357 · Cited by 801
Turner, C. A., Mack, D. H., & Davis, M. M. (1994) · Cell · doi:10.1016/0092-8674(94)90321-2 · Cited by 761
Taylor, A., Verhagen, J., Blaser, K., Akdis, M., & Akdis, C. A. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02321.x · Cited by 720
Augello, A., Tasso, R., Negrini, S. M., Amateis, A., Indiveri, F., Cancedda, R., & Pennesi, G. (2005) · European Journal of Immunology · doi:10.1002/eji.200425405 · Cited by 696
Regulation of hemopoiesis by bone marrow stromal cells and their products
Dorshkind, K. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.000551 · Cited by 504
Mesenchymal stem cells: a new strategy for immunosuppression?
Uccelli, A., Pistoia, V., & Moretta, L. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.03.001 · Cited by 461
Murine marrow‐derived mesenchymal stem cell: isolation, in vitro expansion, and characterization
Meirelles, L. D. S., & Nardi, N. B. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04669.x · Cited by 460
Repression of c- myc Transcription by Blimp-1, an Inducer of Terminal B Cell Differentiation
Lin, Y., Wong, K.-K., & Calame, K. (1997) · Science · doi:10.1126/science.276.5312.596 · Cited by 429
Direct Repression of prdm1 by Bcl-6 Inhibits Plasmacytic Differentiation
Tunyaplin, C., Shaffer, A. L., Angelin-Duclos, C. D., Yu, X., Staudt, L. M., & Calame, K. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1158 · Cited by 376
Delogu, A., Schebesta, A., Sun, Q., Aschenbrenner, K., Perlot, T., & Busslinger, M. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.012 · Cited by 365
Disruption of the Bcl6 Gene Results in an Impaired Germinal Center Formation
Fukuda, T., Yoshida, T., Okada, S., Hatano, M., Miki, T., Ishibashi, K., Okabe, S., Koseki, H., Hirosawa, S., Taniguchi, M., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.3.439 · Cited by 356
Traggiai, E., Volpi, S., Schena, F., Gattorno, M., Ferlito, F., Moretta, L., & Martini, A. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0528 · Cited by 282
Mesenchymal Stem Cells Stimulate Antibody Secretion in Human B Cells
Rasmusson, I., Le Blanc, K., Sundberg, B., & Ringdén, O. (2007) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.01905.x · Cited by 281
Isolation of Mouse Marrow Mesenchymal Progenitors by a Novel and Reliable Method
Sun, S., Guo, Z., Xiao, X., Liu, B., Liu, X., Tang, P., & Mao, N. (2003) · STEM CELLS · doi:10.1634/stemcells.21-5-527 · Cited by 275
Loss of Pax5 Promotes Plasma Cell Differentiation
Nera, K.-P., Kohonen, P., Narvi, E., Peippo, A., Mustonen, L., Terho, P., Koskela, K., Buerstedde, J.-M., & Lassila, O. (2006) · Immunity · doi:10.1016/j.immuni.2006.02.003 · Cited by 232
Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow
Shapiro-Shelef, M., Lin, K.-I., Savitsky, D., Liao, J., & Calame, K. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051611 · Cited by 223
Liu, H., Kemeny, D. M., Heng, B. C., Ouyang, H. W., Melendez, A. J., & Cao, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.2864 · Cited by 217
Vasanwala, F. H., Kusam, S., Toney, L. M., & Dent, A. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1922 · Cited by 199
Stem cell therapy and gene transfer for regeneration
Asahara, T., Kalka, C., & Isner, J. M. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301142 · Cited by 196
Regenerative and immunomodulatory potential of mesenchymal stem cells
KRAMPERA, M., PASINI, A., PIZZOLO, G., COSMI, L., ROMAGNANI, S., & ANNUNZIATO, F. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.02.008 · Cited by 177
Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation
Comoli, P., Ginevri, F., Maccario, R., Avanzini, M. A., Marconi, M., Groff, A., Cometa, A. M., Cioni, M., Porretti, L., Barberi, W., et al. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm740 · Cited by 151
Indoleamine 2,3 dioxygenase and regulation of T cell immunity
Mellor, A. L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.232 · Cited by 149
Fitzgerald, K. A., & Chen, Z. J. (2006) · Cell · doi:10.1016/j.cell.2006.05.014 · Cited by 98
Transcriptional regulatory cascades controlling plasma cell differentiation
Lin, K., Tunyaplin, C., & Calame, K. L. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00040.x · Cited by 95
A Role for c- fos /Activator Protein 1 in B Lymphocyte Terminal Differentiation
Ohkubo, Y., Arima, M., Arguni, E., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7703 · Cited by 78
Itakura, S., Asari, S., Rawson, J., Ito, T., Todorov, I., Liu, C., Sasakic, N., KANDEEL, F. R., & Mullen, Y. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01643.x · Cited by 71
Self-citation
Cited by
Mechanisms of mesenchymal stem/stromal cell function
Spees, J. L., Lee, R. H., & Gregory, C. A. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0363-7 · Cited by 891
Stem Cell Paracrine Actions and Tissue Regeneration
Baraniak, P. R., & McDevitt, T. C. (2010) · Regenerative Medicine · doi:10.2217/rme.09.74 · Cited by 843
Mesenchymal Stem Cells: Mechanisms of Immunomodulation and Homing
Yagi, H., Soto-Gutierrez, A., Parekkadan, B., Kitagawa, Y., Tompkins, R. G., Kobayashi, N., & Yarmush, M. L. (2010) · Cell Transplantation · doi:10.3727/096368910x508762 · Cited by 701
Immune modulation by mesenchymal stem cells
Jiang, W., & Xu, J. (2020) · Cell Proliferation · doi:10.1111/cpr.12712 · Cited by 650
Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications
Ghannam, S., Bouffi, C., Djouad, F., Jorgensen, C., & Noël, D. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt2 · Cited by 507
“Recent studies suggest that MSCs may induce a cytokine profile shift in the Th1/Th2 balance toward the anti-inflammatory phenotype Th2 [35,36] (Bouffi C, Bony C, Courties G, Jorgensen C, Noël D, personal communication).”
Background
Metadata
- Authors
- Asari, S., Itakura, S., Ferreri, K., Liu, C.-P., Kuroda, Y., Kandeel, F., & Mullen, Y.
- Venue
- Experimental Hematology
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 37
- Issue
- 5
- Pages
- 604-615
- ISSN
- 0301-472X (ISSN-L)
- OpenAlex
- W2125442794
- Cited by
- 342
- References
- 45
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.